WCHN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Revenue RecoveryStrong top-line growth indicates improving demand or mix across Wacker’s businesses. If sustained, higher volumes can improve capacity utilization and provide operating leverage, supporting a recovery in profitability over the next several quarters.
Improved Cash GenerationPositive free cash flow and solid operating cash generation provide internal funding for investment, debt service and business resilience. This is especially important while accounting earnings remain weak, although consistency across future periods remains necessary.
Diversified Specialty Chemicals PlatformExposure to multiple specialty chemical and biotech applications reduces dependence on one end market. Integrated manufacturing and specification-driven products can support customer retention, product differentiation and more durable demand than commodity chemicals.
Bears Say
Persistent Losses And Thin MarginsOngoing net losses and minimal operating profitability limit reinvestment capacity and leave earnings highly sensitive to pricing, energy costs and utilization. A durable margin recovery is needed before growth can translate into dependable shareholder returns.
Rising Leverage And Negative ReturnsIncreasing leverage alongside negative returns reduces financial flexibility and can amplify pressure during chemical-market downturns. Although debt is not described as extreme, the direction of leverage and weak profitability create a structural balance-sheet risk.
Volatile Cash ConversionThe sharp variation in free cash flow shows that cash generation is not yet consistently dependable. Volatility may reflect cyclical demand, working-capital movements or investment needs, complicating debt reduction and long-term capital planning.
Wacker Chemie AG News
WCHN FAQ
What was Wacker Chemie AG’s price range in the past 12 months?
Currently, no data Available
What is Wacker Chemie AG’s market cap?
Wacker Chemie AG’s market cap is $89.93B.
When is Wacker Chemie AG’s upcoming earnings report date?
Wacker Chemie AG’s upcoming earnings report date is Oct 29, 2026 which is in 49 days.
How were Wacker Chemie AG’s earnings last quarter?
Wacker Chemie AG released its earnings results on Jul 30, 2026. The company reported $136.493 earnings per share for the quarter, beating the consensus estimate of $7.163 by $129.33.
Is Wacker Chemie AG overvalued?
According to Wall Street analysts Wacker Chemie AG’s price is currently Undervalued.
Does Wacker Chemie AG pay dividends?
Wacker Chemie AG does not currently pay dividends.
What is Wacker Chemie AG’s EPS estimate?
Wacker Chemie AG’s EPS estimate is -4.62.
How many shares outstanding does Wacker Chemie AG have?
Wacker Chemie AG has 52,152,600 shares outstanding.
What happened to Wacker Chemie AG’s price movement after its last earnings report?
Wacker Chemie AG reported an EPS of $136.493 in its last earnings report, beating expectations of $7.163. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Wacker Chemie AG?
Currently, no hedge funds are holding shares in MX:WCHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wacker Chemie AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1,762.04 (― Upside)
$1,762.04 (― Upside)
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Wacker Chemie AG
Wacker Chemie AG is a global enterprise delivering a diverse portfolio of chemical products through its worldwide operations. The company's business is structured across four principal divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones segment produces an extensive array of silicone-based items, including silanes, siloxanes, fluids, emulsions, elastomers, resins, and pyrogenic silicas, which are essential for industries such as construction, electronics, automotive, healthcare, and renewable energy. Meanwhile, Wacker Polymers specializes in the provision of binders and polymeric additives, notably dispersible polymer powders and vinyl acetate-ethylene dispersions, crucial for applications in construction, paper manufacturing, adhesives, paints, coatings, and fundamental chemical processes. Wacker Biosolutions focuses on bespoke biotechnological solutions and a specialized catalog of fine chemicals. Its offerings, encompassing pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, serve as key components for pharmaceutical active ingredients, food additives, and agricultural chemicals. Finally, the Wacker Polysilicon unit is dedicated to manufacturing hyperpure polysilicon, an indispensable material for both the semiconductor and solar energy sectors. Tracing its origins back to 1914, Wacker Chemie AG maintains its headquarters in Munich, Germany, and functions as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
WCHN Company Deck
WCHN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call highlighted ongoing challenges such as decreased sales and EBITDA, negative net income, and a challenging market environment, particularly in Europe. Despite these issues, there are strategic efforts to improve cash flow and reduce costs, with strong performance in the semiconductor polysilicon segment. However, the overall sentiment is affected by the revised downward guidance and persistent market pressures.View all MX:WCHN earnings summariesWCHN Stock 12 Month Forecast
All Analysts
Top Analysts










